CellAxia Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $6.6M
Latest Deal Amount
  • Investors
  • 6

CellAxia General Information

Description

Operator of a biotechnology company intended to develop cell therapy drugs. The company is engaged into on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of intractable autoimmune diseases, enabling researchers to use difficult to transect cells like primary and cancer stem cell cultures and discover new therapeutic cell-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6th floor, Logs Nihonbashi Horidome Building
  • 1-10-9 Nihonbashi Horidome-cho, Chuo-ku
  • Tokyo, 103-0012
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CellAxia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series B) 11-Sep-2020 $6.6M 00.00 Completed Generating Revenue
To view CellAxia’s complete valuation and funding history, request access »

CellAxia Executive Team (1)

Name Title Board Seat Contact Info
Makoto Seki Founder, Chief Executive Officer & President
To view CellAxia’s complete executive team members history, request access »

CellAxia Board Members (3)

Name Representing Role Since
Hiroyuki Misawa Ph.D Miyako Capital Board Member 000 0000
Shuichiro Kadowaki CellAxia Board Member 000 0000
Tadashi Hishida CellAxia Audit & Supervisory Board Member 000 0000
To view CellAxia’s complete board members history, request access »

CellAxia Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FFG Venture Business Partners Venture Capital Minority 000 0000 000000 0
M3 Corporation Minority 000 0000 000000 0
Mitsubishi UFJ Capital Venture Capital Minority 000 0000 000000 0
Miyako Capital Venture Capital Minority 000 0000 000000 0
Mizuho Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »